Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2018 | 1 |
2021 | 2 |
2022 | 2 |
2023 | 2 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Prognostic score for synchronous metastatic rectal cancer: A real-world study.
Dig Liver Dis. 2023 Oct;55(10):1411-1416. doi: 10.1016/j.dld.2023.03.004. Epub 2023 Apr 1.
Dig Liver Dis. 2023.
PMID: 37005173
Patient Preference Between Cabazitaxel and Docetaxel for First-line Chemotherapy in Metastatic Castration-resistant Prostate Cancer: The CABADOC Trial.
Baciarello G, Delva R, Gravis G, Tazi Y, Beuzeboc P, Gross-Goupil M, Bompas E, Joly F, Greilsamer C, Hon TNT, Barthelemy P, Culine S, Berdah JF, Deblock M, Ratta R, Flechon A, Cheneau C, Maillard A, Martineau G, Borget I, Fizazi K; Groupe d’Etude des Tumeurs Uro-Genitales (GETUG)..
Baciarello G, et al. Among authors: greilsamer c.
Eur Urol. 2022 Mar;81(3):234-240. doi: 10.1016/j.eururo.2021.10.016. Epub 2021 Nov 14.
Eur Urol. 2022.
PMID: 34789394
Clinical Trial.
Item in Clipboard
Baseline tumour size is an independent prognostic factor for overall survival in PD-L1 ≥ 50% non-small cell lung cancer patients treated with first-line pembrolizumab.
Bureau M, Chatellier T, Perennec T, Goronflot T, Greilsamer C, Chene AL, Affi R, Frampas E, Bennouna J, Pons-Tostivint E.
Bureau M, et al. Among authors: greilsamer c.
Cancer Immunol Immunother. 2022 Jul;71(7):1747-1756. doi: 10.1007/s00262-021-03108-x. Epub 2021 Nov 28.
Cancer Immunol Immunother. 2022.
PMID: 34839373
Free PMC article.
Item in Clipboard
CHEOPS trial: a GINECO group randomized phase II assessing addition of a non-steroidal aromatase inhibitor to oral vinorelbine in pre-treated metastatic breast cancer patients.
Bailleux C, Arnaud A, Frenel JS, Chabaud S, Bachelot T, You B, Stefani L, Tixidre CG, Simon H, Beal-Ardisson D, Jacquin JP, Del Piano F, Lortholary A, Cornea C, Greilsamer C, Largillier R, Brocard F, Legouffe E, Atlassi M, Hardy-Bessard AC, Heudel PE.
Bailleux C, et al. Among authors: greilsamer c.
Breast Cancer. 2023 Mar;30(2):315-328. doi: 10.1007/s12282-022-01426-1. Epub 2023 Jan 5.
Breast Cancer. 2023.
PMID: 36602669
Free PMC article.
Clinical Trial.
Item in Clipboard
[Early phase trials at the "Institut de cancérologie de l'Ouest": Clinical outcome and validation of prognostic scores].
Greilsamer C, Campion L, Cabart M, Gourmelon C, Senellart H, Bennouna J.
Greilsamer C, et al.
Bull Cancer. 2018 Oct;105(10):896-906. doi: 10.1016/j.bulcan.2018.05.016. Epub 2018 Jun 29.
Bull Cancer. 2018.
PMID: 30348261
French.
Item in Clipboard
Cite
Cite